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Serological Diagnosis of North American Paragonimiasis by Western Blot
Using Paragonimus kellicotti Adult Worm Antigen
Peter U. Fischer,* Kurt C. Curtis, Scott M. Folk, Patricia P. Wilkins, Luis A. Marcos, and Gary J. Weil
Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri;
Heartland Regional Medical Center, St. Joseph, Missouri; Centers for Disease Control and Prevention, Atlanta, Georgia
Abstract. We studied the value of an IgG Western blot (WB) with Paragonimus kellicotti (Pk) antigen for diagnosis of
North American paragonimiasis. The test was evaluated with sera from patients with Pk and Paragonimus westermani
infections, with control sera from patients with other helminth infections, and sera from healthy Americans. All 11 proven
Pk infection sera and two samples from suspected cases that were negative by P. westermaniWB at the Centers for Disease
Control and Prevention (CDC) contained antibodies to antigens at 34 kDa and at 21/23 kDa. Seven of 7 P. westermani sera
contained antibodies to the 34 kDa antigen, but only 2 recognized the 21/23 kDa doublet. No control samples were reactive
with these antigens. Antibody reactivity declined after praziquantel treatment. Thus, the P. kellicotti WB appears to be
superior to P. westermaniWB for diagnosing Pk infections, and it may be useful for assessing responses to treatment.
INTRODUCTION
Most human Paragonimus infections occur in the Far East,
but Paragonimus species are also present in other parts of Asia,
in sub-Saharan Africa, and in the Americas. North American
paragonimiasis (NAP) caused by Paragonimus kellicotti, is a
rare human infection, but the zoonosis appears to be emerging
in the United States. Only six cases of endemic paragonimiasis
were reported from Colorado, Iowa, Michigan, Missouri, and
Oklahoma between 1965 and 2007. Since then nine additional
cases have been published fromMissouri alone, all of themafter
the consumption of raw or undercooked crayfish during canoe-
ing or camping trips.1,2
Laboratory diagnosis of NAP by parasitology is difficult,
because most infected individuals do not have eggs detected in
stool, sputum, bronchoalveolar lavage fluid, pleural effusions,
or lung biopsies. Paragonimus kellicotti parasites require about
6 to 8 weeks in the mammalian host before they begin produc-
ing eggs. Previous case reports showed that months or years
may pass between the onset of the illness and parasitological
diagnosis.3,4 Diagnosis was often delayed for many months
after the onset of symptoms, and patients often failed thera-
peutic trials of antibiotics and/or steroids before proper diag-
nosis and treatment.
Serologic testing is an important tool for diagnosis of infec-
tions with Paragonimus westermani and related Old World
flukes, however experience with its use in P. kellicotti infec-
tion is limited. Although serologic tests using P. westermani
antigens can be used to diagnose P. kellicotti infection,2,4
an assay using the infecting parasite species might be more
sensitive than one using an antigen extract prepared from a
heterologous species.
The primary purpose of this study was to test the value of
an immunoglobulin G (IgG) Western blot with P. kellicotti
antigen as a diagnostic tool for NAP. We also examined the
timing of antibody responses to P. kellicotti antigen in exper-
imentally infected gerbils and assessed the persistence of anti-
bodies in patients with NAP after praziquantel treatment.
MATERIAL ANDMETHODS
Patient sera. The study protocol was approved by theHuman
Research Protection Office atWashingtonUniversity School of
Medicine. De-identified patient samples were obtained from
Barnes Jewish Hospital in St. Louis, Missouri, the Centers
of Diseases Control and Prevention (CDC) in Atlanta, and
Heartland RegionalMedical Center in St. Joseph,MO. The serum
samples were classified according to infection status as shown
in Table 1. The panel of sera included samples from individuals
with proven P. kellicotti infection, samples from suspected
P. kellicotti cases, samples from patients with P. westermani
infection, samples from individuals with other helminth infec-
tions, and samples from healthy Americans. In addition, sera of
Americanswith a rheumatoid factorwere tested, because it is pos-
sible that this could lead to false positive results. Paragonimus
kellicotti infection cases were considered to be proven if they
had a history of crayfish ingestion with an illness consistent
with NAP plus a positive P. westermani serology at CDC
and/or P. kellicotti eggs or DNA in their sputum, lung
tissue biopsies, or stool. In addition, these patients had no
recent history of international travel and their symptoms
improved promptly after praziquantel treatment. Suspected
NAP cases had compatible case histories with negative
P. westermani serology at CDC and no DNA or parasitological
evidence of infection.
Animal sera. The animal study protocol was approved
by the Animal Studies Committee at Washington University
School of Medicine. Mongolian gerbils were infected with
P. kellicotti metacercariae as previously described.5 Venous
blood was collected from infected Mongolian gerbils at vari-
ous time points after infection (p.i.). Plasma was separated
and preserved at −20°C until use.
Paragonimus antigens. Adult P. kellicotti worms were
obtained from experimentally infected Mongolian gerbils,
and soluble total worm antigen was prepared as described
previously.5 A P. westermani Chafee extract of adult worms
was provided by CDC.6,7 Excretory/secretory (e/s) antigens
of P. kellicotti were obtained by culturing two adult flukes
(65 days p.i.) overnight in 500 mL phosphate buffered saline
(PBS) at room temperature. After removal of the living flukes,
the eggs were removed (~2,000 eggs) by sedimentation for 3 h
at 4°C. The supernatant was centrifuged at 19,000 + g for
15 min, and the protein concentration of the supernatant was
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determined using the Pierce BCA method (Thermo Fisher
Scientific, Rockford, IL). The e/s antigen was aliquoted and
stored at −70°C until use.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE). Parasite antigen was electrophoresed using
4–12% NuPAGE Bis-Tris minigels (Invitrogen, Carlsbad,
CA). Gels were fixed, washed, and stained using FASTSilver
(G-Biosciences, St. Louis, MO) according to the manufac-
turer’s instructions.
Western blot.Western blot was performed with three types
of antigen (P. kellicotti total worm antigen, P. kellicotti e/s
antigen, and P. westermani total worm antigen) as described
previously for P. kellicotti.5 Briefly, 10 mg of antigen per cm
was separated on a 4–12% reducing gel, blotted onto a nitro-
cellulose membrane, blocked at room temperature for 30 min
using 5% non-fat dry milk (BioRad, Hercules, CA) in PBS,
and incubated with patient or animal serum or plasma at a
dilution of 1:100 or 1:50, respectively. Serum and secondary
antibody were diluted in PBS-tween and incubated at 37°C for
1 and 2 h, respectively. After incubation with a secondary anti-
body (alkaline phosphatase conjugated anti-human IgG [H+L],
for human samples or anti-mouse IgG [H+L] for gerbil samples,
Promega, Sunnyvale, CA), blots were washed with PBS-tween,
and antibody binding was detected using nitro-blue tetrazolium/
5-bromo-4-chloro-3¢-indolyphosphate substrate (Sigma, St. Louis,
MO). The detection of IgG4 subclass antibodies to helminth anti-
gens frequently increases the specificity of serological assays.
Therefore, human IgG4 subclass antibodies were detected as
previously described with horseradish peroxidase conjugated
monoclonal antibody to human IgG4 (HP6023) and substrate.8
RESULTS
Identification of diagnostic proteins. We used 11 sera from
individuals with proven P. kellicotti or P. westermani infection
to identify immunoreactive proteins in the soluble P. kellicotti
adult worm antigen extract with diagnostic potential. Fourteen
proteins with molecular mass values between 4 and 62 kDa
were recognized by antibodies in at least one serum sample
from patients with P. kellicotti or P. westermani infection
(Table 2). Three of these proteins at 21, 23, and 34 kDa were
recognized by all 11 sera from proven P. kellicotti cases
(Figure 1, lanes 1, 8, and 9). Therefore, we considered patient
sera from North Americans with antibody reactivity to the 21/
23kDadoublet or the34kDabandbyWesternblot tobepositive
for antibodies to P. kellicotti. Interestingly, the two serum sam-
ples from individuals with suspected P. kellicotti infection also
contained antibodies to these three antigen bands.All seven sera
tested from patients with P. westermani infection had antibodies
Table 1
Serum samples used to evaluate the Western blot assay based on Paragonimus kellicotti adult worm antigen in this study
Serum group No. of samples Characterization
Pk cases 11 Sera from patients with clinical signs of paragonimiasis, positive IgG Western blots with P. westermani
antigens at CDC6; positive history of crayfish consumption, no travel outside the United States.
Suspected Pk cases 2 Sera from North American patients with clinical signs of paragonimiasis who had negative IgG Western
blots with P. westermani antigens at CDC6; positive history of crayfish consumption, no travel outside
the United States.
Potential Pk exposure 11 Sera from individuals from Missouri without clinical signs of paragonimiasis who may have eaten
raw crayfish.
P. westermani cases 7 Sera from patients from the Philippines with proven P. westermani infection; eggs were detected
in stool, positive Western blots with P. westermani antigens at CDC.6
P. kellicotti treated cases 7 Sera from patients with P. kellicotti infections (see above) collected 4–28 weeks post treatment
with praziquantel.
Healthy Americans 14 Sera from Americans with no reason to suspect paragonimiasis (WUSM).
Rheumatoid factor 4 Sera from Americans with rheumatoid factor (titers ³ 1:64, WUSM).
Schistosoma infection 21 Sera from patients with proven Schistosoma mansoni, S. haematobium, or S. japonicum infection
(CDC, Uganda).
Fasciola hepatica infection 10 Sera from patients with proven fasciolasis (CDC).
Echinococcus granulosus 2 Sera from patients with clinical echinococcosis (CDC)
Strongyloides stercoralis 6 Sera from African patients with parasitologically proven strongyloidiasis (Uganda).
Table 2
IgG reactivity by Western blot with selected Paragonimus kellicotti adult worm antigens for sera from individuals with paragonimiasis and various
types of control sera*
Serum group
Molecular mass, kDa
4 8 12 14 21 22 23 29 34 44 47 49 55 62
Pk cases (N = 11) 3 6 6 7 11 0 11 1 11 4 4 7 2 7
Suspected Pk cases (N = 2) 0 0 0 0 2 0 2 0 2 2 0 0 0 2
Potential Pk exposure (N = 11) 0 0 0 0 0 6 0 0 0 6 0 6 0 0
P. westermani (N = 7) 5 6 5 4 2 1 2 0 7 3 2 3 2 2
Healthy North Americans (N = 14) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Rheumatoid factor (N = 4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Schistosoma infections (N = 21) 0 0 0 0 0 11 0 0 0 4 0 9 0 0
Fasciola hepatica (N = 10) 0 0 0 0 0 10 0 0 0 0 0 0 0 0
Echinococcus granulosus (N = 2) 0 0 0 0 0 2 0 0 0 2 1 2 0 0
Strongyloides stercoralis (N = 6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
*Numbers refer to the number of sera reactive with various antigens.
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to the 34 kDa protein, but only two reacted with the 21/23 kDa
doublet proteins.
Specificity of the P. kellicotti diagnostic proteins. None of
the 57 sera we tested from parasite-free individuals or from
individuals with other helminth infections reacted with the
21/23 or 34 kDa proteins in the soluble P. kellicotti adult
worm antigen extract (Table 1). Some of the sera reacted with
other proteins (for example, see lanes 11 and 12 in Figure 1).
However, these patterns were easily differentiated from those
produced by sera from paragonimiasis patients. The use of
anti-IgG4 as a secondary antibody did not significantly reduce
nonspecific reactivity with other antigens in control samples or
enhance reactivity of positive samples with the diagnostic
antigen bands (data not shown).
Reactivity to excretory/secretory P. kellicotti antigens. The
e/s antigen was tested by Western blot with sera from proven
P. kellicotti cases. The sera strongly recognized a 21/23 kDa
doublet and had weak reactivity with a more diffuse band at
34 kDa (Figure 2). These results suggest that the 21/23 kDa
doublet antigen and possibly the 34 kDA antigen are excreted
or secreted by living adult P. kellicotti worms.
Emergence and persistence of antibodies to P. kellicotti
antigens. Serial serum samples from P. kellicotti-infected
gerbils were tested by Western blot to determine the timing
of antibody responses to P. kellicotti antigens in the soluble
P. kellicotti adult worm antigen extract. Specific IgG anti-
bodies were detected as early as 2 weeks p.i., and all infected
gerbils had detectable antibody responses 5 weeks after infec-
tion. Sera from infected gerbils did not recognize the same
antigens in P. kellicotti extract as human sera; the two most
prominent antigens recognized by gerbil sera have molecu-
lar masses of ~28 and 55 kDa (compare with Figure 2B in
Reference 5). The reason for the differential antigen recogni-
tion of gerbils and humans is not known.
To determine the persistence of P. kellicotti antibodies
after successful treatment with praziquantel, we tested sera
from five proven P. kellicotti cases before and after treat-
ment. Although all sera were still positive 5 to 9 weeks
after treatment, two post-treatment sera produced weaker
Figure 1. Total IgG Western blot using soluble Paragonimus
kellicotti adult worm antigen tested with sera from individuals with or
without proven Paragonimus infection. Lane 1, positive control serum
from a patient from St. Joseph, Missouri with proven P. kellicotti infec-
tion; lane 2, negative control serum from a healthy American with-
out exposure to Paragonimus; lanes 3–7, sera from patients from the
Philippines with proven Paragonimus westermani infection; lanes 8 and
9, sera from patients with proven P. kellicotti infection from Missouri;
lanes 10 and 11, sera from patients with Echinococcus granulosus infec-
tion; lanes 12 and 13, sera from patients with schistosomiasis.
Figure 2. Western blot using Paragonimus kellicotti adult worm
excretory/secretory antigen (lane 1) or soluble total worm antigen
(lane 2) using a serum specimen fromapatient infectedwithP. kellicotti.
Figure 3. Western blot detection of antibodies to soluble
Paragonimus kellicotti adult worm antigen in sera from P. kellicotti
patients before or after treatment with praziquantel. Lanes 1, 3, 5, and
7, sera from four patients with proven P. kellicotti infections before
treatment; lane 2, serum from the same patient as in lane 1 collected
5 weeks after treatment with praziquantel; lane 4, serum from the same
patient as in lane 3 collected 8 weeks after treatment with praziquantel;
lane 6, serum from the same patient as in lane 5 collected 9 weeks
after treatment with praziquantel; lane 8, serum from the same patient
as in lane 7 collected 7 weeks after treatment with praziquantel.
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reactions than pretreatment sera from the same individuals
(Figure 3, compare lanes 5, 6, and 7, 8). One serum from a
confirmed P. kellicotti case (with positive P. kellicotti and
P. westermani Western blots before treatment) was collected
28 weeks after treatment, and this was negative for anti-
bodies to P. kellicotti by Western blot (data not shown). These
results suggest that antibodies to P. kellicotti decrease after
praziquantel treatment and that they might be useful as a test
of cure for the infection.
Comparison of Western blot results obtained with
P. kellicotti and P. westermani adult worm antigens. The two
antigen preparations were studied by SDS-PAGE (Figure 4).
The silver stain showed that both antigen preparations con-
tained a large number of strong, distinct bands. Some of these
protein bands were apparently shared between the two antigen
preparations (e.g., antigens at ~25 kDa, ~13 kDa, and ~5 kDa).
Overall, bands were stronger and more distinct in the P. kellicotti
antigen extract. None of the proteins in the P. westermani
antigen extract was clearly identifiable as one of the diagnostic
proteins in the P. kellicottiWestern blot.
Tocompare the suitability of theP.kellicottiandP.westermani
antigens for the Western blot diagnosis of NAP, we performed
blots with both antigens using the same set of patient sera. Both
antigens showed almost no background with sera of healthy
Americans or other individuals without Paragonimus infection
(Figure 5). Sera fromconfirmedP.kellicotti cases recognized the
diagnostic proteins at 34 and 21/23 kDa. Sera from confirmed
P. westermani cases reacted strongly with the P. kellicotti anti-
gens at 34 kDa but in 5 of 7 cases not with those at 21/23 kDa. In
addition, some of these serum samples strongly reacted with
high molecular weight proteins (see lanes 3 and 4 in Figure 5).
Sera fromP. kellicotti andP.westermanipatients tended to react
more weakly with P. westermani antigens than with P. kellicotti
antigens; they reactedmost stronglywithP.westermani antigens
between 38 and 42 kDa and between 21 and 25 kDa. Analysis of
13 sera from P. kellicotti cases and 7 sera of P. westermani cases
using both antigens showed that all 20 sera were positive for
antibodies to P. kellicotti antigen, whereas 18 (90%) were posi-
tive with the P. westermani antigen. Two sera from suspected
P. kellicotti cases were reactive byWestern blot withP. kellicotti
antigen but not withP. westermani antigen.
DISCUSSION
To improve the serological diagnosis of NAP, we devel-
oped a simple and reliable Western blot assay using soluble
P. kellicotti adult worm antigen. All sera from patients with
NAP had positive antibody tests, and the assay appears to be
highly specific for infection with Paragonimus species.
Three antigens at 21, 23, and 34 kDa in the P. kellicotti adult
worm antigen extract were recognized by all 11 proven NAP
cases. Although sera from P. westermani patients consistently
recognized the 34 kDA protein in P. kellicotti antigen, none of
the sera tested from patients without Paragonimus infection
contained antibodies that reacted with these three “diagnostic”
antigens. These antigens are clearly different from the 8 kDa
P. westermani antigen that was previously reported to be spe-
cific for paragonimiasis.6 Another study showed that only a
31.5 kDa protein in the Paragonimus heterotremus antigen
was recognized by all sera from proven paragonimiasis cases.9
It is possible that this P. heterotremus antigen corresponds to
the 34 kDa protein recognized by all NAP and P. westermani
cases in this study. Another study reported a non-protein
antigen at 35 kDa as a major diagnostic antigen for that infec-
tion.10 Unfortunately, most serological studies on human
paragonimiasis have used the enzyme-linked immunosorbent
assay (ELISA) for antibody detection without providing infor-
mation about the molecular mass of the antigens recognized by
antibodies in sera from infected individuals. Although the
ELISA format is more convenient than the Western blot, it is
not ideal for use with crude native antigen extracts that may
contain cross-reactive antigens together with specific diagnostic
Figure 4. A silver stained SDS page gel shows the major proteins
in Paragonimus kellicotti soluble adult worm antigen (lanes 2–4) and
in Paragonimus westermani antigen (lanes 5–7). Lane 1, molecular
weight markers; lanes 2 and 7, 250 ng protein per lane; lanes 3 and 6,
500 ng protein per lane; lanes 4 and 5, 1 mg protein per lane.
Figure 5. Comparison of Paragonimus kellicotti (lanes 1–7) and
Paragonimus westermani antigen (lanes 8–14) for detecting antibodies
to Paragonimus antigens by Western blot. Lanes 1 and 8 tested serum
from a suspected P. kellicotti patient (later considered to have not been
infected) who did not have antibodies to either antigen; lanes 2 and
9 and 5 and 12 were tested with sera from two proven P. kellicotti
patients; lanes 3 and 10 and lanes 4 and 11 tested sera from two
proven P. westermani patients; lanes 6 and 13 and lanes 7 and 14 tested
sera from two healthy Americans without exposure to Paragonimus.
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antigens.Western blot assays are satisfactory for rare infections
like NAP, because the number of sera to be tested is small,
and high throughput screening is not required.
The diagnostic 21/23 kDa proteins in the P. kellicotti anti-
gen extract are e/s antigens, and e/s antigens have been previ-
ously used for the serological diagnosis of P. heterotremus
infection.11 The 21/23 doublet antigens were excreted and/or
secreted into PBS after a simple overnight culture of a small
number of P. kellicotti adult worms. Additional work will be
required to further characterize these antigens.
Our results showed that gerbils produce IgG antibodies to
P. kellicotti antigens as early as 2 weeks p.i. Furthermore,
some of the NAP sera we tested were obtained shortly after
the onset of symptoms and within a few months after crayfish
ingestion. Positive antibody tests with these sera contrast with a
report that stated that human IgG antibodies are mainly seen
in long-standing P. westermani infections, whereas only IgM is
detected in early stages of infection.12 Although it is always
difficult to directly compare results from naturally occurring
infections in humans and experimental infections in animals,
our results suggest that humans with NAP generally have posi-
tive IgG antibody tests soon after the onset of pulmonary
symptoms. It is also important to note that the P. kellicotti
Western blot can also be used to assess the outcome of treat-
ment. Antibody reactivity decreased within weeks of treatment
in several cases. In another case, a patient’s serum became
antibody negative 28 weeks after successful treatment. All of
the NAP cases who provided sera for this study were success-
fully treated using praziquantel.2
The P. kellicotti antigen was not only useful for detecting
cases of NAP, but sera from patients with P. westermani infec-
tions acquired in the Philippines also recognized proteins in the
P. kellicotti extract. The SDS-PAGE analysis suggested that
the P. kellicotti adult worm antigen extract used in this study
contained more proteins that were better resolved than the
P. westermani antigen extract. The P. westermani antigen used
in this study was produced many years ago using ether to
extract undesirable lipids (Chaffee extract) from the adult
P. westermaniworm preparation.7 Ether extraction is no longer
a preferred method for antigen preparation, so the P. kellicotti
adult worm antigen extract described in this work may be a
useful alternative for diagnosis of paragonimiasis caused by
P. kellicotti or P. westermani. Molecular phylogenetic studies
using mitochondrial or non-coding DNA markers indicate that
P. westermani and P. kellicotti are not closely related within the
genus Paragonimus.5,13,14 However, these studies provide little
information about cross-reactivity of diagnostic antigens. In the
past, worm extracts or e/s antigens from a number of old-world
Paragonimus species suchasP.westermani,P.heterotremus, and
Paragonimus africanus have been used for serological diagnosis
of paragonimiasis.6,15–18 Only a few studies identified single
antigens of P. westermani with diagnostic potential. Since the
P. kellicotti adult worm transcriptome has been sequenced
(Mitreva M, McNulty SN, and others, unpublished data), we
were able to compare the amino acid sequences of several of
the previously described Paragonimus antigens to predicted
sequences of P. kellicotti orthologues. For example, a cysteine
proteinase (cp2) had only 53% identity with the P. kellicotti
orthologue andamajor egg antigenhad 86% identity.19,20 These
results are in line with our observations that show that sera
of NAP cases show stronger reactions with homologous
P. kellicotti antigens than with P. westermani antigens.
In conclusion, we have developed and evaluated a Western
blot assay for the detection of IgG antibodies to P. kellicotti
adult worm antigens for the serological diagnosis of NAP.
This test appears to be sensitive and specific for human
paragonimiasis. Antibodies to P. kellicotti appear within a few
weeks after infection in animals and arepresentwhenpulmonary
symptoms develop in humans. Antibody reactivity wanes over a
period ofmonths after successful treatment with praziquantel.
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